Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity

Authors:

Abstract
Sandhoff disease (SD) is a lysosomal storage disease, caused by loss of β-hexosaminidase (HEX) activity resulting in the accumulation of ganglioside GM2. There are shared features between SD and Parkinson’s disease (PD). α-synuclein (aSYN) inclusions, the diagnostic hallmark sign of PD, are frequently found in the brain in SD patients and HEX knockout mice, and HEX activity is reduced in the substantia nigra in PD. In this study, we biochemically demonstrate that HEX deficiency in mice causes formation of high-molecular weight (HMW) aSYN and ubiquitin in the brain. As expected from HEX enzymatic function requirements, overexpression in vivo of HEXA and B combined, but not either of the subunits expressed alone, increased HEX activity as evidenced by histochemical assays. Biochemically, such HEX gene expression resulted in increased conversion of GM2 to its breakdown product GM3. In a neurodegenerative model of overexpression of aSYN in rats, increasing HEX activity by AAV6 gene transfer in the substantia nigra reduced aSYN embedding in lipid compartments and rescued dopaminergic neurons from degeneration. Overall, these data are consistent with a paradigm shift where lipid abnormalities are central to or preceding protein changes typically associated with PD.
Funding Information
  • Michael J. Fox Foundation for Parkinson's Research
  • National Institute of Neurological Disorders and Stroke (1R01NS092667)
  • National Institute on Aging (R01AG060195)
  • U.S. Department of War (W81XWH2010368, W81XWH2010371)
  • The Consolidated Anti-Aging Foundation
  • The Orchard Foundation
  • Harold and Ronna Cooper Post-Doctoral Fellowship for Parkinson’s Disease Research
  • Parkinson's UK
  • Wellcome Trust
  • Royal Society Wolfson Research Merit

This publication has 56 references indexed in Scilit: